ClinicalTrials.govpublic full text
Cabozantinib and Pembrolizumab for the First-Line Treatment of Advanced Liver Cancer
advanced hepatocellular carcinoma, bclc stage b hepatocellular carcinoma, bclc stage c hepatocellular carcinoma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 857754
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.